La chaîne d'options affiche les données clés des options sur actions de Cabot à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Cabot..

Cabot (NYSE:CBT) Stock, Chaîne d'Options

Cabot

Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.

Cabot Corp

XTRA Bitcoin Inc

Cannabotech Ltd

CITIZENS BNCRP INVT INC A by Citizens Bancorp Investment, Inc.

Citizens Bancorp Investment Inc

CATHEDRA BITCOIN SUB VTG by Cathedra Bitcoin Inc

Cathedra Bitcoin Inc

FMC Corporation&#39;s (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) stock looks promising at the moment. It benefits from efforts to expand its product portfolio through new product launches and its restructuring actions.
Let&#39;s see what makes FMC stock a compelling investment option at the moment.
<h2>FMC Stock Outperforms Industry</h2>
FMC has outperformed the industry it belongs to over the past three months. The company&#39;s shares have gained 13.8% compared with a 7.7% rise of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/c7/80480.jpg?v=1918707670" />
Image Source: Zacks Investment Research
<h2>FMC&#39;s Valuation Looks Attractive</h2>
FMC&#39;s attractive valuation should lure investors seeking value. The stock is currently trading at a forward 12-month earnings multiple of 14.52X, representing a roughly 12.4% discount when stacked up with the industry average of 16.58X. FMC also has a Value Score of B.
<h2>FMC&#39;s Earnings Estimates Going Up</h2>
Earnings estimates for FMC have been going up over the past 60 days. The Zacks Consensus Estimate for 2024 has increased by 0.6%. The consensus estimate for 2025 has also been revised 3.5% upward over the same time frame.
<h2>New Products, Restructuring Actions Aid FMC Stock</h2>
FMC remains focused on strengthening its product portfolio. It is investing in technologies as well as new product launches to enhance value to the farmers. New products launched in Europe, North America and Asia are gaining significant traction. Product introductions are expected to support the company&#39;s results this year.
FMC generated $590 million in sales in 2023 from new products launched in the past five years. It expects revenues from new products to grow by roughly $200 million in 2024. It expects a significant amount of volume growth to come from new products in the second half of 2024. FMC is seeing strong gains in new products including Coragen eVo and Premio Star insecticides and the Onsuva fungicide in Latin America.
The acquisition of BioPhero ApS, a Denmark-based pheromone research and production company, also adds biologically produced state-of-the-art pheromone insect control technology to the company&#39;s product portfolio and R&amp;D pipeline, highlighting FMC&#39;s role as a leader in delivering innovative and sustainable crop protection solutions.
The company is also expected to benefit from reduced input costs, favorable product mix and its cost-control actions. It benefited from favorable input costs in the second quarter of 2024. FMC is also making progress with its global restructuring and cost-reduction program. It sees benefits from restructuring to contribute $75-$100 million to full-year 2024 adjusted EBITDA, net of inflation.
<div class="chart_embed">
<h3>FMC Corporation Price and Consensus</h3>
<img alt="FMC Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/17/1728291628.png" style="height:265px; width:576px" title="" />
FMC Corporation price-consensus-chart | FMC Corporation Quote
</div>
<h2>FMC&#39;s Zacks Rank &amp; Other Key Picks</h2>
FMC currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the Basic Materials space are IAMGOLD Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iag#NYSE">IAG</a>), Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) and Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>). While IAMGOLD sports a Zacks Rank #1 (Strong Buy), Cabot and Axalta Coating carry a Zacks Rank #2.
The Zacks Consensus Estimate for IAMGOLD&#39;s current-year earnings has increased by 45.4% in the past 60 days. IAG beat the consensus estimate in each of the last four quarters with the average surprise being 200%. Its shares have shot up roughly 132% in the past year.
The consensus estimate for Cabot&#39;s current fiscal year earnings is pegged at $7.07 per share, indicating a year-over-year rise of 31.4%. The consensus estimates for CBT&#39;s current-year earnings has increased by 4.3% in the past 60 days. The company&#39;s shares have rallied roughly 61% in the past year.
The Zacks Consensus Estimate for Axalta Coating&#39;s current year earnings is pegged at $2.07, indicating a rise of 31.9% from year-ago levels. The Zacks Consensus Estimate for AXTA&#39;s current year earnings has increased 2.5% in the past 60 days. The stock has gained around 32% in the past year.
<a href="https://www.zacks.com/stock/news/2346902/here-s-why-you-should-add-fmc-stock-to-your-portfolio-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2346902">To read this article on Zacks.com click here.</a>

Earnings

Earnings Beats

Mid Cap

News

Penny Stocks

Markets

Analyst Ratings

Trading Ideas

AXTA

Here's Why You Should Add FMC Stock to Your Portfolio Now

Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) recently announced that the U.S. Department of Energy&#39;s (&quot;DOE&quot;) Office of Manufacturing and Energy Supply Chains has selected it for an award negotiation for up to $50 million. This award, which is part of the Bipartisan Infrastructure Law, will help Cabot develop a new manufacturing facility in the United States to make battery-grade carbon nanotubes (CNTs) and conductive additive dispersions on a commercial scale.
These minerals are crucial to the domestic lithium-ion battery supply chain for electric cars (EVs) and the electrical grid, reducing reliance on imports. The DOE funding will cover approximately 30% of the project&#39;s entire anticipated investment of $181 million. Cabot intends to revitalize, retrofit and restore a former automotive site in Wayne County, MI, to become the United States&#39; first production facility for battery-grade CNTs and conductive additive dispersions.
Cabot has teamed up with the North American Building Trades Union, the International Chemical Workers Union Council and the Michigan Building and Construction Trades Council to support this project, which is expected to generate hundreds of new construction and full-time manufacturing jobs. This new manufacturing operation will strengthen the domestic supply chain for crucial battery ingredients, lowering dependency on foreign imports.
This investment emphasizes Cabot&#39;s role as a key participant in the energy transition, offering breakthrough material solutions not only in battery technologies but also throughout the energy storage and management ecosystem. Cabot&#39;s contributions go beyond conductive additives, including aerogels for improved thermal management, metal oxides for cathode durability and novel carbons for fuel cell optimization, all of which are critical for the next generation of sustainable energy solutions.
Shares of Cabot have gained 62% in the past year against a 1.4% decline of the industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/4b/78742.jpg?v=1030981076" />
Image Source: Zacks Investment Research
CBT anticipates fiscal 2024 adjusted earnings per share of $7.00 to $7.10. This range represents a 30 cents increase at the midpoint, driven by the company&#39;s expectations for improved results in the Performance Chemicals segment due to higher demand and a more favorable product mix compared to the first half of the year, as well as continued strong results in the Reinforcement Materials unit.
<div class="chart_embed">
<h3>Cabot Corporation Price and Consensus</h3>
<h2><img alt="Cabot Corporation Price and Consensus" src="https://staticx-tuner.zacks.com/images/charts/99/1727087188.png" style="height:265px; width:583px" title="" /></h2>
Cabot Corporation price-consensus-chart | Cabot Corporation Quote
</div>
<h2>Zacks Rank &amp; Key Picks</h2>
CBT currently carries a Zacks Rank #3 (Hold).
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Eldorado Gold Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ego#NYSE">EGO</a>) and Hawkins, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hwkn#NASDAQ">HWKN</a>).
Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy). CRS beat the Zacks Consensus Estimate in each of the last four quarters, with the average earnings surprise being 15.9%. The company&#39;s shares have soared 111.7% in the past year.
The Zacks Consensus Estimate for Eldorado&#39;s current-year earnings is pegged at $1.35 per share, indicating a year-over-year rise of 136.8%. EGO, a Zacks Rank #1 stock, beat the consensus estimate in each of the last four quarters, with the average earnings surprise being 430.3%. The company&#39;s shares have rallied roughly 71.6% in the past year.
The Zacks Consensus Estimate for Hawkins&#39; current fiscal-year earnings is pegged at $4.14, indicating a rise of 15.3% from year-ago levels. The Zacks Consensus Estimate for HWKN&#39;s current fiscal-year earnings has increased 12.8% in the past 60 days. HWKN, a Zacks Rank #2 (Buy) stock, has rallied around 99.1% in the past year.
<a href="https://www.zacks.com/stock/news/2339654/cabot-chosen-for-50m-award-negotiation-to-aid-battery-supply-chain?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2339654">To read this article on Zacks.com click here.</a>

HWKN

Cabot Chosen for $50M Award Negotiation to Aid Battery Supply Chain

Cabot Corporation Chosen For $50M Award Negotiation By U.S. Department Of Energy To Develop First Commercial-Scale Battery Material Facility In The U.S.

Have you been paying attention to shares of Cabot (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>)? Shares have been on the move with the stock up 8.8% over the past month. The stock hit a new 52-week high of $108.39 in the previous session. Cabot has gained 28.7% since the start of the year compared to the -3.7% move for the Zacks Basic Materials sector and the -2.3% return for the Zacks Chemical - Diversified industry.
<h2>What&#39;s Driving the Outperformance?</h2>
The stock has an impressive record of positive earnings surprises, as it hasn&#39;t missed our earnings consensus estimate in any of the last four quarters. In its last earnings report on August 5, 2024, Cabot reported EPS of $1.92 versus consensus estimate of $1.74.
For the current fiscal year, Cabot is expected to post earnings of $7.07 per share on $4.01 billion in revenues. This represents a 31.41% change in EPS on a 2% change in revenues. For the next fiscal year, the company is expected to earn $7.82 per share on $4.21 billion in revenues. This represents a year-over-year change of 10.61% and 5.04%, respectively.
<h2>Valuation Metrics</h2>
Cabot may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company has run ahead of itself.
On this front, we can look at the Zacks Style Scores, as they provide investors with an additional way to sort through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style.
Cabot has a Value Score of A. The stock&#39;s Growth and Momentum Scores are A and D, respectively, giving the company a VGM Score of A.
In terms of its value breakdown, the stock currently trades at 15.2X current fiscal year EPS estimates, which is not in-line with the peer industry average of 18.3X. On a trailing cash flow basis, the stock currently trades at 13.2X versus its peer group&#39;s average of 8.6X. Additionally, the stock has a PEG ratio of 1. This isn&#39;t enough to put the company in the top echelon of all stocks we cover from a value perspective.
<h2>Zacks Rank</h2>
We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, Cabot currently has a Zacks Rank of #2 (Buy) thanks to favorable earnings estimate revisions from covering analysts.
Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if Cabot meets the list of requirements. Thus, it seems as though Cabot shares could have potential in the weeks and months to come.
<a href="https://www.zacks.com/stock/news/2337750/cabot-corporation-cbt-hit-a-52-week-high-can-the-run-continue?cid=CS-BENZ-FT-52_week_high-2337750">To read this article on Zacks.com click here.</a>

Cabot Corporation Hit a 52 Week High, Can the Run Continue?

Revealing a significant insider sell on August 28, Jeff Ji Zhu, Executive Vice President at Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>), as per the latest SEC filing.
What Happened: Zhu opted to sell 14,912 shares of Cabot, according to a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000016040/000095017024101452//Archives/edgar/data/16040/000095017024101452/0000950170-24-101452-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The transaction's total worth stands at $1,551,510.
At Thursday morning, Cabot shares are down by 0.0%, trading at $103.09.
<h3>About Cabot</h3>
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
<h3>Cabot's Financial Performance</h3>
Revenue Growth: Cabot displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 4.96%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Interpreting Earnings Metrics:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 25.2%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Cabot's EPS is a standout, portraying a positive bottom-line trend that exceeds the industry average with a current EPS of 1.96.
</li>
</ul>
Debt Management: Cabot's debt-to-equity ratio is below the industry average at 0.85, reflecting a lower dependency on debt financing and a more conservative financial approach.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 12.3 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 1.45, Cabot's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 8.73, Cabot presents an attractive value opportunity.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Cracking Transaction Codes</h3>
When analyzing transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> tend to focus on those in the open market, detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase,while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000016040">Check Out The Full List Of Cabot's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Decision: Jeff Ji Zhu Offloads $1.55M Worth Of Cabot Stock

Erica McLaughlin, Executive Vice President at Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>), reported a large exercise of company stock options on August 28, according to a new SEC filing.
What Happened: In an insider options sale disclosed in a Form 4 filing on Wednesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000016040/000095017024101450//Archives/edgar/data/16040/000095017024101450/0000950170-24-101450-index.htm">U.S. Securities and Exchange Commission</a>, McLaughlin, Executive Vice President at Cabot, exercised stock options for 16,390 shares of CBT. The transaction value amounted to $867,450.
Cabot shares are currently trading down by 0.0%, with a current price of $103.09 as of Thursday morning. This brings the total value of McLaughlin's 16,390 shares to $867,450.
<h3>Unveiling the Story Behind Cabot</h3>
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
<h3>A Deep Dive into Cabot's Financials</h3>
Revenue Growth: Cabot's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 4.96%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Profitability Metrics:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 25.2%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Cabot's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.96.
</li>
</ul>
Debt Management: Cabot's debt-to-equity ratio is below the industry average. With a ratio of 0.85, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Valuation Overview:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 12.3 is lower than the industry average, implying a discounted valuation for Cabot's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 1.45, Cabot's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Indicated by a lower-than-industry-average EV/EBITDA ratio of 8.73, the company suggests a potential undervaluation, which might be advantageous for value-focused investors.
</li>
</ul>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000016040">Check Out The Full List Of Cabot's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Executive Vice President At Cabot Exercises Options Worth $867K

A large exercise of company stock options by Hobart Kalkstein, Executive Vice President at Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) was disclosed in a new SEC filing on August 21, as part of an insider exercise.
What Happened: Kalkstein, Executive Vice President at Cabot, made a strategic move by exercising stock options for 20,320 shares of CBT as detailed in a Form 4 filing on Wednesday with the <a href="https://www.sec.gov/Archives/edgar/data/0000016040/000095017024099553//Archives/edgar/data/16040/000095017024099553/0000950170-24-099553-index.htm">U.S. Securities and Exchange Commission</a>. The transaction value amounted to $1,208,430.
The latest update on Thursday morning shows Cabot shares down by 0.57%, trading at $100.44. At this price, Kalkstein's 20,320 shares are worth $1,208,430.
<h3>About Cabot</h3>
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
<h3>Financial Milestones: Cabot's Journey</h3>
Revenue Growth: Over the 3 months period, Cabot showcased positive performance, achieving a revenue growth rate of 4.96% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 25.2%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Cabot's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.96.
</li>
</ul>
Debt Management: Cabot's debt-to-equity ratio is below the industry average at 0.85, reflecting a lower dependency on debt financing and a more conservative financial approach.
Understanding Financial Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 12.05 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a higher-than-average P/S ratio of 1.42, Cabot's stock is perceived as being overvalued in the market, particularly in relation to sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 8.58, Cabot's EV/EBITDA ratio reflects a below-par valuation compared to industry averages signalling undervaluation
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Essential Transaction Codes Unveiled</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000016040">Check Out The Full List Of Cabot's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Move: Hobart Kalkstein Exercises Options, Realizing $1.21M At Cabot

A significant insider transaction involving the exercise of company stock options was reported on August 12, by Erica McLaughlin, Executive Vice President at Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>), as per the latest SEC filing.
What Happened: McLaughlin, Executive Vice President at Cabot, exercised stock options for 11,082 shares of CBT stock. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000016040/000095017024095523//Archives/edgar/data/16040/000095017024095523/0000950170-24-095523-index.htm">U.S. Securities and Exchange Commission</a> on Monday. The exercise price of the options was $50.06 per share.
The Tuesday morning market activity shows Cabot shares down by 0.0%, trading at $95.23. This implies a total value of $500,545 for McLaughlin's 11,082 shares.
<h3>About Cabot</h3>
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
<h3>Unraveling the Financial Story of Cabot</h3>
Positive Revenue Trend: Examining Cabot's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.96% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 25.2%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Cabot's EPS is a standout, portraying a positive bottom-line trend that exceeds the industry average with a current EPS of 1.96.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.85.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 11.36, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 1.34 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Cabot's EV/EBITDA ratio, lower than industry averages at 8.16, indicates attractively priced shares.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
Insider transactions, although significant, should be considered within the larger context of market analysis and trends.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>The Insider's Guide to Important Transaction Codes</h3>
Taking a closer look at transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, meticulously cataloged in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C denotes the conversion of an option, and transaction code A signifies a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000016040">Check Out The Full List Of Cabot's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Erica McLaughlin Exercises Options, Realizes $500K

A large exercise of company stock options by Erica McLaughlin, Executive Vice President at Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) was disclosed in a new SEC filing on August 8, as part of an insider exercise.
What Happened: McLaughlin, Executive Vice President at Cabot, exercised stock options for 23,274 shares of CBT stock. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000016040/000095017024094204//Archives/edgar/data/16040/000095017024094204/0000950170-24-094204-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The exercise price of the options was $50.12 per share.
As of Friday morning, Cabot shares are down by 0.24%, with a current price of $97.0. This implies that McLaughlin's 23,274 shares have a value of $1,091,046.
<h3>Unveiling the Story Behind Cabot</h3>
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
<h3>Cabot: Delving into Financials</h3>
Revenue Growth: Cabot's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 4.96%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Key Insights into Profitability Metrics:
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 25.2%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Cabot's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.96.
</li>
</ul>
Debt Management: Cabot's debt-to-equity ratio is below the industry average. With a ratio of 0.85, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 11.6 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: A higher-than-average P/S ratio of 1.37 suggests overvaluation in the eyes of investors, considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry averages at 8.31, Cabot could be considered undervalued.
</li>
</ul>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Illuminating the Importance of Insider Transactions</h3>
While insider transactions provide valuable information, they should be part of a broader analysis in making investment decisions.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000016040">Check Out The Full List Of Cabot's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Erica McLaughlin At Cabot Capitalizes: Options Exercised, Resulting In $1.09M

JP Morgan analyst Jeffrey Zekauskas maintains Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) with a Neutral and raises the price target from $95 to $105.

Price Target

JP Morgan Maintains Neutral on Cabot, Raises Price Target to $105

WIIM

Cabot shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 guidance.

U.S. stocks were higher, with the Dow Jones index gaining over 300 points on Tuesday.
Shares of Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) rose sharply during Tuesday's session after the company reported better-than-expected second-quarter earnings and <a href="https://www.benzinga.com/news/earnings/24/08/40181443/restaurant-company-yum-china-posts-mixed-q2-results-announces-cfo-change">announced a CFO transition.</a>
Core operating profit grew 12% Y/Y to $275 million, with a margin of 10.0% vs. 9.3% a year ago quarter. EPS of 55 cents surpassed the street view of 47 cents.
Yum China shares surged 11.6% to $33.26 on Tuesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Lumen Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUMN#NYSE">LUMN</a>) shares surged 90% to $4.92 after the company announced it secured $5 billion in new business from companies seeking to secure their fiber capacity.</li>
<li>Clear Secure, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOU#NYSE">YOU</a>) gained 26.4% to $24.61 after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.</li>
<li>Serve Robotics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERV#NASDAQ">SERV</a>) climbed 24.9% to $17.01 after falling around 7% on Monday.</li>
<li>TG Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TGTX#NASDAQ">TGTX</a>) gained 21.2% to $20.85  after the company reported better-than-expected quarterly financial results and raised its FY24 Briumvi U.S. net product revenue. The company entered into a term loan facility with Blue Owl Capital.</li>
<li>Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) rose 17.8% to $25.76 after the company reported better-than-expected second-quarter financial results and increased its FY24 revenue guidance above estimates.</li>
<li>Bioventus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVS#NASDAQ">BVS</a>) jumped 18.5% to $7.42 after the company reported better-than-expected second-quarter financial results and raised its FY24 guidance above estimates.</li>
<li>Vimeo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMEO#NASDAQ">VMEO</a>) gained 17.2% to $4.18 after the company reported better-than-expected quarterly financial results and raised its FY24 revenue guidance.</li>
<li>Cabot Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) rose 15.2% to $100.21 following upbeat quarterly results.</li>
<li>Kenvue Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) climbed 13.7% to $20.69 after the company reported better-than-expected quarterly financial results.</li>
<li>Vornado Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNO#NYSE">VNO</a>) gained 13.2% to $30.85 following better-than-expected quarterly earnings.</li>
<li>New Oriental Education &amp; Technology Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDU#NYSE">EDU</a>) gained 11.6% to $72.87  after the company upsized its share repurchase program.</li>
<li>BellRing Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) gained 11.2% to $54.85 following upbeat quarterly earnings.</li>
<li>TransMedics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) gained 9.3% to $162.20.</li>
<li>BioMarin Pharmaceutical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) rose 9.3% to $87.99 after the company reported better-than-expected quarterly financial results. Also, Evercore ISI Group maintained an Outperform rating on the stock and raised its price target from $113 to $115.</li>
<li>Royal Caribbean Cruises Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCL#NYSE">RCL</a>) rose 9.1% to $152.55. The company announced that it entered into exchange agreements with a limited number of noteholders of its 6% Convertible Senior Notes due 2025</li>
<li>Materion Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTRN#NYSE">MTRN</a>) gained 9% to $112.74 following strong quarterly earnings.</li>
<li>Planet Fitness, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLNT#NYSE">PLNT</a>) rose 9% to $78.53 after the company reported better-than-expected second-quarter financial results and reiterated 2024 outlook.</li>
<li>Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) rose 6.7% to $54.58  after the company reported better-than-expected quarterly financial results.</li>
<li>Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) gained 5.9% to $105.02 after B of A Securities upgraded the stock from Neutral to Buy.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/news/24/08/40188563/this-crowdstrike-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday"> </a>
<ul>
<li><a href="https://www.benzinga.com/news/24/08/40188563/this-crowdstrike-analyst-turns-bullish-here-are-top-5-upgrades-for-tuesday">This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday</a></li>
</ul>

Intraday Update

Movers

BMRN

BRBR

CSTL

New Oriental Education & Technology Group

KVUE

LUMN

MTRN

PLNT

SERV

TGTX

TMDX

VMEO

YUMC

Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday

UBS analyst Joshua Spector maintains Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) with a Neutral and lowers the price target from $103 to $98.

UBS Maintains Neutral on Cabot, Lowers Price Target to $98

Outlook
Commenting on the outlook for the Company, Keohane said, "Given the strong year-to-date results and our expectations for the fourth fiscal quarter, we are raising our adjusted EPS guidance range for fiscal 2024 to $7.00 to $7.10 from our previously communicated range of $6.65 to $6.85. This updated guidance range reflects an increase of $0.30 at the midpoint driven by our expectations for improved results in the Performance Chemicals segment from higher demand and a more favorable product mix as compared to the first half of the year and continued strong results in the Reinforcement Materials segment.
Keohane continued, "With one quarter to go in fiscal 2024, we are on track to deliver greater than 30% year-over-year adjusted EPS growth. Our strong cash flow and disciplined and balanced approach to capital allocation has allowed us to invest in key growth projects and return capital to shareholders. I believe Cabot is executing well against our "Creating for Tomorrow" strategy and our long-term targets to deliver attractive shareholder returns.&nbsp; Our revised outlook for adjusted EPS in fiscal 2024 would place us at or above the high-end of our targeted range of 8% to 12% adjusted EPS compound annual growth rate from fiscal 2021. Also, we remain on track to deliver our target of more than $1 billion of cumulative discretionary free cash flow over the last three fiscal years."

Guidance

Cabot Raises FY24 EPS Range From $6.65-$6.85 To $7.00-$7.10 Vs $6.74 Est.

Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) reported quarterly earnings of $1.92 per share which beat the analyst consensus estimate of $1.72 by 11.63 percent. This is a 35.21 percent increase over earnings of $1.42 per share from the same period last year. The company reported quarterly sales of $1.02 billion which beat the analyst consensus estimate of $1.00 billion by 1.60 percent. This is a 4.96 percent increase over sales of $968.00 million the same period last year.

Cabot Q3 Adj $1.92 Beats $1.72 Estimate, Sales $1.02B Beat $1.00B Estimate

CF Industries Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cf#NYSE">CF</a>) is poised to gain from higher nitrogen fertilizer demand in major markets and lower natural gas costs amid headwinds from softer nitrogen prices.
The company&#39;s shares have declined 4.1% over a year compared with a 25.3% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/b7/70849.jpg?v=912933296" />
Image Source: Zacks Investment Research
Let&#39;s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
<h3>CF Gains on Healthy Nitrogen Demand, Lower Gas Costs</h3>
CF Industries is benefiting from rising global demand for nitrogen fertilizers, driven by significant agricultural demand. Industrial demand for nitrogen has also recovered from the pandemic-related disruptions. The company sees global demand to remain strong in the near future due to recovering industrial demand and farmer economics.
High levels of corn planted acres, low nitrogen channel inventories and favorable farm economics are expected to drive demand for nitrogen in North America. Demand for urea is also expected to remain strong in Brazil and India. Demand in India is expected to be driven by an uptick in domestic production on the back of higher operating rates and favorable weather conditions.
CF also stands to benefit from lower natural gas prices. It witnessed a significant decline in natural gas costs in the first quarter of 2024. The average cost of natural gas fell to $3.19 per MMBtu in the quarter from $6.62 per MMBtu in the year-ago quarter. Lower natural gas costs led to a decline in the company&#39;s cost of sales. The benefits of reduced gas costs are expected to continue in the second quarter of 2024.
Moreover, CF remains committed to boosting shareholders&#39; value by leveraging strong cash flows. In the first quarter of 2024, the company repurchased 4.3 million shares for $347 million. The current $3 billion share repurchase program had around $2.2 billion remaining at the end of the first quarter. Earlier this year, the company also announced a 25% increase in quarterly dividend to 50 cents per share.
<h3>Weaker Nitrogen Prices Weigh on Margins</h3>
CF is exposed to headwinds from softer nitrogen prices. Global nitrogen prices have declined since the beginning of 2023. Higher global supply availability driven by higher global operating rates due to lower global energy costs has resulted in a decline in prices. Lower average selling prices weighed on CF&#39;s top line in the first quarter.
Selling prices fell in the quarter as decreased global energy costs reduced the global market clearance price required to meet global demand. The weak pricing environment is expected to continue over the near term. Lower pricing is likely to continue weighing on the company&#39;s sales and margins.
<h3>Stocks to Consider</h3>
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>) and Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>).
Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy). CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 15.1%. The company&#39;s shares have soared roughly 90% in the past year.
Axalta Coating Systems, carrying a Zacks Rank #2 (Buy), has a projected earnings growth rate of 26.8% for the current year. In the past 60 days, the consensus estimate for AXTA&#39;s current-year earnings has been revised upward by 5.9%. The company&#39;s shares have gained roughly 3% in the past year.
Cabot currently carries a Zacks Rank #2. CBT has a projected earnings growth rate of 29% for the current fiscal year. The company&#39;s shares have rallied around 33% in the past year.
<a href="https://www.zacks.com/stock/news/2299045/here-s-why-you-should-hold-onto-cf-industries-cf-stock-for-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2299045">To read this article on Zacks.com click here.</a>

Here's Why You Should Hold Onto CF Industries Stock for Now

Celanese Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ce#NYSE">CE</a>) is expected to benefit from its investments in high-return organic projects, cost and productivity actions and synergies of acquisitions. However, it faces headwinds from weak demand in certain end markets and pricing pressures.
The company&#39;s shares have gained 14.6% in a year against a 13.3% decline of its industry.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/18/70695.jpg?v=594454220" />
Image Source: Zacks Investment Research
Let&#39;s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
<h3>Acquisitions &amp; Productivity Aid Celanese</h3>
Celanese&#39;s strategic acquisitions have provided it with opportunities for additional growth, investment and synergies. The acquisition of the majority of DuPont&#39;s Mobility &amp; Materials (&quot;M&amp;M&quot;) business has allowed Celanese to enhance its growth in high-value applications. Celanese expects incremental M&amp;M synergies of at least $150 million during 2024.
The acquisitions of SO.F.TER., Nilit and Omni Plastics are also expected to contribute to earnings expansion in the company&#39;s Engineered Materials segment. The Elotex acquisition also strengthened the company&#39;s position in the vinyl acetate ethylene emulsions space. Moreover, the purchase of Exxon Mobil&#39;s Santoprene business broadened the company&#39;s portfolio of engineered solutions and enabled it to offer a wider range of functionalized solutions to targeted growth areas, including future mobility, medical and sustainability.
Celanese also remains focused on executing its productivity programs including the implementation of several cost-reduction capital projects. Productivity actions are expected to support its margins in 2024.
The company is proactively implementing strategic initiatives recognizing the volatility and unpredictability of the current market landscape and competitive environment. These actions involve strengthening its commercial teams, aligning production and inventory levels with prevailing demand, implementing cost-saving measures and optimizing cash flow. These endeavors are expected to result in strong cash generation and a continuation of earnings growth.
Celanese has also completed the startup of a new 1.3-million-ton Clear Lake acetic acid expansion unit and a new vinyl acetate ethylene unit in Nanjing. It expects the Clear Lake expansion to contribute to higher earnings performance in the second quarter and into the second half of 2024.
Moreover, Celanese continues to generate strong cash flows and is focused on boosting shareholders&#39; value and deleveraging its balance sheet. It generated a record operating cash flow of $1.9 billion and a free cash flow of $1.3 billion in 2023. CE returned $305 million to shareholders through dividend payouts during 2023. Moreover, the company reduced its net debt by $1.3 billion in 2023. It expects to continue reducing its net debt in 2024. The company, in its first-quarter call, said that it expects to repay over $2 billion in total debt maturities over the next four quarters.
<h3>Soft Demand &amp; Pricing a Concern</h3>
CE is exposed to headwinds from demand softness in some of its end markets. It witnessed weak demand in several end markets and destocking in 2023. Soft demand led to inventory reduction and deferral of orders by the company&#39;s customers. Demand remains sluggish in industrial and consumer goods end markets. The company continues to see subdued demand in Europe. Demand conditions are yet to return to normal levels. Weaker demand recovery globally is likely to weigh on the company&#39;s volumes in the near term.
Celanese is also being challenged by significant competition. Competitive pressure is hurting its prices. CE saw lower pricing on a year-over-year basis across its segments in the first quarter. The company expects the pricing pressure to continue due to the challenging competitive dynamics in the second quarter of 2024.
<h3>Stocks to Consider</h3>
Better-ranked stocks in the basic materials space include Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>) and Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>).
CRS beat the Zacks Consensus Estimate in three of the last four quarters while matching it once, with the average earnings surprise being 15.1%. The company&#39;s shares have soared roughly 93% in the past year. Carpenter Technology currently carries a Zacks Rank #1 (Strong Buy).
Axalta Coating Systems, carrying a Zacks Rank #2 (Buy), has a projected earnings growth rate of 26.8% for the current year. In the past 60 days, the consensus estimate for AXTA&#39;s current-year earnings has been revised upward by 5.9%. The company&#39;s shares have gained roughly 6% in the past year.
Cabot currently carries a Zacks Rank #2. CBT has a projected earnings growth rate of 26% for the current fiscal year. The company&#39;s shares have rallied around 33% in the past year.
<a href="https://www.zacks.com/stock/news/2298431/here-s-why-you-should-hold-onto-celanese-ce-stock-for-now?cid=CS-BENZ-FT-analyst_blog|rank_focused-2298431">To read this article on Zacks.com click here.</a>

Here's Why You Should Hold Onto Celanese Stock for Now

Investors in Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) need to pay close attention to the stock based on moves in the options market lately. That is because the Jul 19, 2024 $80 Call had some of the highest implied volatility of all equity options today.
<h3>What is Implied Volatility?</h3>
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
<h3>What do the Analysts Think?</h3>
Clearly, options traders are pricing in a big move for Cabot shares, but what is the fundamental picture for the company? Currently, Cabot is a Zacks Rank #2 (Buy) in the Chemical - Diversified industry that ranks in the Bottom 27% of our Zacks Industry Rank. Over the last 60 days, three analysts have increased their earnings estimates for the current quarter, while one has dropped the estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from $1.72 per share to $1.74 in that period.
Given the way analysts feel about Cabot right now, this huge implied volatility could mean there&#39;s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
<a href="https://www.zacks.com/stock/news/2296504/do-options-traders-know-something-about-cabot-cbt-stock-we-don-t?cid=CS-BENZ-FT-tale_of_the_tape|options-2296504">To read this article on Zacks.com click here.</a>

Options

Do Options Traders Know Something About Cabot Stock We Don't?

The chemical industry is poised to benefit from an uptick in demand in certain key markets, including consumer durables and building &amp; construction, as the unprecedented customer inventory de-stocking that started in late 2022 and plagued the industry through the first quarter of 2024 is largely complete. 
In addition to the expected demand rebound, strategic measures, including operating cost reduction and price hike actions along with declining raw material costs, bode well for the industry. Stocks like DuPont de Nemours, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dd#NYSE">DD</a>), Axalta Coating Systems Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/axta#NYSE">AXTA</a>), Cabot Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cbt#NYSE">CBT</a>) and Kronos Worldwide, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kro#NYSE">KRO</a>) are good choices for investment as they are expected to benefit from the demand upturn. 
The chemical space bore the brunt of the demand slowdown in certain major markets in 2023, which continued through first-quarter 2024. The downturn in the building &amp; construction market and the de-stocking in consumer electronics played spoilsport, leading to demand destruction in these key markets. In North America, uncertainties surrounding the U.S. housing market weighed on building &amp; construction. Notably, the housing market bore the brunt of interest rate hikes last year. The demand slowdown in industrial and consumer durables hurt the volumes of chemical companies. 
Lower consumer spending due to inflationary pressures in Europe and a slow recovery in China also impacted demand. Moreover, a slower recovery in economic activities in China following the lifting of the restrictions related to the resurgence in COVID-19 infections hurt chemical demand in that country. The slowdown in Europe, resulting from the war in Ukraine and weaker consumer spending due to high levels of inflation, led to softer demand in that region. The energy and feedstock inflation resulted in reduced industrial production and consumer spending in Europe. 
Nevertheless, customer inventory de-stocking has largely ended, leading to low inventory levels. This should result in an uptick in chemical demand and volumes, with a meaningful improvement expected in the second half of 2024. The de-stocking was primarily driven by high inflation and the lingering impacts of the pandemic that affected customer spending. 
Demand for chemicals in the automotive market has picked up, aided by an uptick in automotive production on an improved supply of semiconductors. The resolution to the six-week United Auto Workers strike also led to a rebound in chemical demand in automotive. Moreover, chemical companies are seeing a recovery in demand across the construction and electronics markets. Demand in healthcare and packaging markets also remains steady. 
Moderating raw material and energy costs driven by the easing of supply-chain disruptions is also expected to act as a tailwind. Meanwhile, industrial production is picking up pace in China on a recovery in external demand, underscoring improving conditions in the world&#39;s second-largest economy. However, the recovery in domestic demand in China remains slow due to the protracted crisis in real estate. Easing inflation on a decline in energy prices is also likely to support demand recovery in Europe.&nbsp;
<h3>4 Chemical Stocks Worth a Bet</h3>
A rebound in end-market demand, moderating raw material and energy costs, and the absence of customer inventory destocking augur well for the chemical industry. 
We highlight the following four stocks with a solid Zacks Rank that are good options for investment right now. Our research shows that stocks with a Zacks Rank #1 (Strong Buy) or 2 (Buy) offer good investment opportunities. 
DuPont: Delaware-based DuPont is benefiting from innovation-driven investment focused on several high-growth areas. It remains focused on driving growth through innovation and new product development. The acquisition of Spectrum Plastics Group has also strengthened DuPont&#39;s position in stable and fast-growing healthcare end markets. DuPont is also benefiting from cost synergy savings and productivity improvement actions. Its planned separation into three independent, publicly traded companies is also expected to drive significant growth opportunities. 
DuPont, sporting a Zacks Rank #1, has expected earnings growth of 4.3% for 2024. The Zacks Consensus Estimate for DD&#39;s earnings for 2024 has been revised upward by 4.3% over the last 60 days. It beat the Zacks Consensus Estimate for earnings in each of the last four quarters at an average of roughly 9%. 
Axalta Coating Systems: Pennsylvania-based Axalta is benefiting from the strength in refinish and light vehicle businesses, which is offsetting the weakness in industrial markets. The acquisition of CoverFlexx Group will enhance Axalta&#39;s refinish business by incorporating CoverFlexx&#39;s extensive range of automotive refinish and aftermarket coatings, including primers, basecoats, clearcoats and various detailing products. Axalta has also strategically expanded its portfolio by acquiring Andre Koch AG, a well-established Refinish distribution partner headquartered in Switzerland. Moreover, AXTA has raised its full-year 2024 earnings and free cash flow outlook based on strong first-quarter results and strategic actions to drive earnings. 
Axalta, carrying a Zacks Rank #1, has expected earnings growth of 26.8% for 2024. The Zacks Consensus Estimate for AXTA&#39;s 2024 earnings has been revised upward by 5.9% over the last 60 days. 
Cabot: Massachusetts-based Cabot is seeing strong results in its Reinforcement Materials segment driven by higher volumes in Asia and Europe, pricing and mix improvements, and the strength in the replacement tire market. Demand in the Performance Chemicals unit has also improved as de-stocking has ended. CBT&#39;s strong cash generation also facilitates a balanced capital allocation approach that emphasizes strategic investments, long-term earnings growth and shareholder returns while preserving a solid investment-grade balance sheet. 
Cabot, a Zacks Rank #2 stock, has expected earnings growth of 26% for fiscal 2024. The Zacks Consensus Estimate for CBT&#39;s earnings for fiscal 2024 has been revised upward by 3% over the last 60 days. 
Kronos Worldwide: Texas-based Kronos is expected to gain from higher demand for titanium dioxide (TiO2). Stronger demand for TiO2 in primary markets of Europe and North America is likely to drive its sales volumes. KRO is also expected to benefit from easing pricing pressure. Reduced energy costs, along with cost-reduction initiatives are expected to support margins. 
Kronos Worldwide, carrying a Zacks Rank #2, has expected earnings growth of 297.7% for 2024. The Zacks Consensus Estimate for KRO&#39;s earnings for 2024 has been revised upward by 157.6% over the last 60 days.
<a href="https://www.zacks.com/stock/news/2288317/4-top-chemical-stocks-to-buy-as-destocking-has-run-its-course?cid=CS-BENZ-FT-analyst_blog|investment_ideas-2288317">To read this article on Zacks.com click here.</a>

Small Cap

4 Top Chemical Stocks to Buy As Destocking Has Run Its Course

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Cabot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBT#NYSE">CBT</a>) in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Cabot and provided 12-month price targets. The average target is $102.75, accompanied by a high estimate of $109.00 and a low estimate of $95.00. Observing a 5.57% increase, the current average has risen from the previous average price target of $97.33. 
<img src="https://www.benzinga.com/files/images/story/2024/1715101259_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Cabot among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$103.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$109.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$95.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>John Roberts</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Buy</td>
<td>$104.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Cabot. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Cabot compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Cabot's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Cabot's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/CBT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cabot analyst ratings.</a>
<h2>Unveiling the Story Behind Cabot</h2>
Cabot Corp manufactures and sells a variety of chemicals, materials, and chemical-based products. The company organizes itself into two segments based on the product type. The reinforcement materials segment, which generates more revenue than any other segment, sells rubber-grade carbon black products used in hoses and belts in automobiles. The performance chemicals segment sells ink-jet colorants and metal oxides used in the automotive and construction industries.
<h3>Unraveling the Financial Story of Cabot</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Cabot's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -0.73%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 5.11%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Cabot's ROE stands out, surpassing industry averages. With an impressive ROE of 3.78%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.34%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.99.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For Cabot

Cabot Non-GAAP EPS of $1.92 beats by $0.21, revenue of $1.02B beats by $20M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Cabot (NYSE:<a href="https://investorplace.com/stock-quotes/cbt-stock-quote/">CBT</a>) just reported results for the third quarter of 2024.<ul><li>Cabot reported earnings per share of $1.92. This was above the analyst estimate for EPS of $1.72.</li><li>The company reported revenue of $1.02 billion.</li><li>This was 1.60% better than the analyst estimate for revenue of $1.00 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/cbt-stock-earnings-cabot-for-q3-of-2024/">CBT Stock Earnings: Cabot Beats EPS, Beats Revenue for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CBT Stock Earnings: Cabot Beats EPS, Beats Revenue for Q3 2024

Cabot Corporation 2024 Q3 - Results - Earnings Call Presentation

Cabot Corporation (CBT) Q3 2024 Earnings Call Transcript

Stocks are higher as the market rebounds from a staggering global selloff.

Dow Up Over 450 Points As Big Tech Stocks Bounce

Dividend Champion, Contender, And Challenger Highlights: Week Of August 25

Dividend Champion, Contender, And Challenger Highlights: Week Of September 8

Fidelity Select Materials Portfolio Q2 2024 Review

DoE awards $3B for 25 projects to boost U.S. battery production

Janus Henderson High-Yield Fund Q2 2024 Commentary

ABAT

ACES

AGCO

ALRS

ALSN

AMAT

ARES

ARTNA

AUBN

AVGO

AVNT

BATT

BOKF

BPOP

BPRN

BRKL

CABO

CADE

CASS

CBOE

CCFN

CFFI

CGNX

CNRG

COFS

CPKF

CRAI

CSGS

CSHJF

CSWC

CTBI

CTRA

CTSH

CTVA

CUKPF

CWEN

DRIV

EBAY

EFSC

EQNR

ERTH

ESNT

EVBN

FBCG

FBCV

FBND

FBTC

FCFS

FCLD

FCOM

FCOR

FCPI

FDBC

FDHY

FDIG

FDIS

FDLO

FDMO

FDRR

FDVV

FENY

FETH

FFIN

FHLC

FIDI

FIDU

FISI

FMAG

FMAT

FMBH

FMET

FMNB

FNCL

FQAL

FQVLF

FREL

FSFG

FSMD

FSTA

FTEC

FUTY

FVAL

FXNC

GATX

GCBC

GILD

GRMN

GWRS

HAIL

HLNE

HOFT

HTBI

HTLF

HUBB

HWBK

IBOC

ICLN

IDRV

JBSS

KARS

KFRC

KNSL

LCII

LCNB

LDOS

LMAT

LSTR

MBCN

MGEE

Comments

Cabot

Cabot (CBT) Options

Cabot (NYSE:CBT) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL